Cell surface markers, also known as cell identification clusters of differentiation (CD), are proteins or glycoproteins expressed on the outer surface of cells. They play a crucial role in cell signaling, cell adhesion, immune response and other physiological processes. Detection of surface markers helps identify various types of cells such as leukocytes, lymphocytes and malignant cells. Advancements in flow cytometry technologies coupled with availability of monoclonal antibodies specific for cell surface antigens have enabled accurate detection and characterization of cell phenotypes. This has found wide applications in disease diagnostics, stem cell research and development of immunotherapies.
The global Cell Surface Markers Detection Market is estimated to be valued at US$ 5,459.5 Mn in 2023 and is expected to exhibit a CAGR of 9.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Get more insights on this topic: https://www.coherentmarketinsights.com/market-insight/cell-surface-markers-detection-market-5581
Market key trends:
One of the major trends driving the cell surface markers detection market growth is the continued expansion of stem cell research activities. Identification of specific markers on stem cells enables isolation, characterization and targeted differentiation into desired cell lineages. This bodes well for development of novel regenerative medicine therapies. Another key trend is the rising demand for personalized medicine approaches. Detection of tumor-specific surface antigens facilitates development of targeted immune therapies against specific cancers. Growing prevalence of chronic diseases worldwide is also fueling the need for immuno-oncology and immunotherapy research which relies heavily on analysis of cell surface protein expression profiles.
Porter’s Analysis
Threat of new entrants: The cell surface markers detection market requires heavy investments in research and development to develop novel products. Therefore, the threat of new entrants is moderate.
Bargaining power of buyers: The bargaining power of buyers in the market is high as the industry players operate in a fragmented competitive landscape with no clear leader.
Bargaining power of suppliers: The cell surface markers detection market has a significant number of instrument and reagents suppliers. Therefore, the bargaining power of suppliers is high.
Threat of new substitutes: There is a low threat of new substitutes in this market as cell surface markers detection is highly specialized with limited substitutes.
Competitive rivalry: The competitive rivalry in the market is high owing to the presence of several global as well as regional players offering similar products.
Key Takeaways
The global cell surface markers detection market is expected to witness high growth.
The market in North America region currently dominates due to developed healthcare infrastructure and presence of leading market players in the region. Factors such as increasing research funding and rising applications of cell surface markers are driving the growth of the market in this region.
The Asia Pacific region is expected to witness fastest growth over the forecast period owing to improving healthcare infrastructure, rising medical tourism, and growing penetration of major market players in countries such as China and India. Growing expenditure on healthcare sector by governments is also supporting the market growth in the Asia Pacific region.
Key players operating in the cell surface markers detection market are Grifols SA, Abbott Laboratories, Sysmex Corporation, Agilent Technologies. These players are focusing on new product launches and expansions to strengthen their position in the market. For instance, in 2022, Sysmex Corporation launched a new automated hematology analyzer, XN-Series, for cell surface markers analysis.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it